Ownership Summary
Barinthus Biotherapeutics plc. (NASDAQ:BRNS) showed up in the 13F filings of 13 institutional investors as of December 2025.
- Their combined ownership stood at 19.4% of outstanding shares in December 2025, down from 22.5% in September 2025.
- They increased total shares held in Barinthus Biotherapeutics by 3.83% from the prior quarter, while the number of investors in BRNS decreased 23.53% year over year.
- Of these 13 funds, 5 grew their exposure to Barinthus Biotherapeutics, 2 cut back, and 6 maintained positions.
- Combined, these investors held 7.9Mn shares in BRNS for December 2025, up by 291.83K shares quarter on quarter, and down 1.82Mn shares year over year.
- DC Funds, LP is the top holder of Barinthus Biotherapeutics as of December 31, 2025, with 642.2K shares representing 1.58% of outstanding stock.
- Per Business Quant, the top 1 investors in BRNS for the quarter ending December 2025 include DC Funds, LP (642.2K).